Sopharma AD operates in the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sopharma AD with three other
drug stores in Europe:
sales of 692.96 million Euro [US$777.73 million]
Sopharma Trading AD
(905.33 million Bulgarian Lev [US$519.71 million]
Dermapharm Holding SE
based in Germany
(572.42 million Euro [US$642.45 million]
of which 58%
was Pharmaceuticals and other products).
Sopharma AD reported sales of 1.19 billion Bulgarian Lev (US$684.78 million)
December of 2018.
increase of 16.3%
versus 2017, when the company's sales were 1.03 billion Bulgarian Lev.